Purchase Order 36C25024P1211
- Not listed
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of a SERVICE AGREEMENT FOR CEPHEID GENEXPERT. The $136,750.00 contract was awarded on July 1, 2021 by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21, and has a completion date of June 30, 2022. The contract is Firm Fixed Price and does not utilize any set-aside designation. As the original equipment...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, with a ceiling value of $86,563.00, is for a CEPHEID SERVICE CONTRACT GENEXPERT-INFINITY. The contract has no set-aside designation and is a Blanket Purchase Agreement (BPA) call. Cepheid will provide molecular diagnostic testing equipment, reagents, test kits, and associated maintenance services to support clinical...
- This federal contract award is for a GeneXpert lease and supplies, awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $456,729.39 and is a firm fixed-price delivery order, with no set-aside designation. Cepheid, the prime contractor, provides molecular diagnostic testing equipment, reagents, and associated maintenance...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Firm Fixed Price purchase order to Cepheid for the lease of GeneXpert Analyzers. The $253,342.20 contract, which has no set-aside designation, runs through September 30, 2023. Cepheid, as the original equipment manufacturer, is providing the...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the CEPHEID GENEXPERT TEST SYSTEM and associated cost-per-test services. The contract, valued at $274,815.58, is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 21. The contract has an ultimate completion date of September 30, 2026 and does not have a set-aside designation. Cepheid is the prime contractor and is...
- This federal contract award, with a ceiling value of $14,177.85, was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger indefinite delivery vehicle (IDV) held by Cepheid for the provision of its GeneXpert diagnostic equipment, reagents, consumables, and maintenance services to VA medical facilities nationwide. This contract does not have a...
- This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, was issued by the Department of Veterans Affairs (VA) for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The $13,096.80 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract with VA Veterans Integrated Service Network 17 for COVID-19 and respiratory virus testing supplies. There is no set-aside...
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, was made by the Department of Veterans Affairs (VA) Veterans Health Administration. The $148,585 firm fixed price purchase order is for the GENEXPERT product, which supports the agency's Coronavirus COVID-19 response. The award does not utilize a set-aside designation. As the original equipment manufacturer, Cepheid has an ongoing relationship providing reagents, test kits, instruments, and...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for CEPHEID GENEXPERT MAINTENANCE AND SUPPORT. The contract, awarded by the Veterans Integrated Service Network 20 of the U.S. Department of Veterans Affairs, has a ceiling value of $96,099.72 and is a firm fixed-price delivery order with a performance period ending on February 4, 2025. The contract is not designated as a set-aside. Cepheid is an experienced federal contractor, providing...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The $148,585.00 contract is for the procurement of Cepheid's GeneXpert diagnostic equipment, reagents, and consumables to support COVID-19 testing. It is issued under Cepheid's existing Multiple Award Schedule (MAS) contract with the General Services Administration. The...
This contract is for GENX SERVICE and was awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract has a ceiling value of $158,360.00 and is a Firm Fixed Price Purchase Order. The awarding agency is the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10. The contract does not have a set-aside designation. Cepheid is the prime contractor and has received multiple federal contract awards and subcontracts from the VA, Defense Logistics Agency, and Department of Health and Human Services to provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to support clinical testing programs, including for COVID-19, influenza, respiratory viruses, and sexually transmitted diseases. Cepheid has also participated as a subrecipient on federal grants to collaborate on tuberculosis diagnostic improvement efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $31.7k | 3/19/25 | |
| Not listed | Not listed | $31.7k | 6/11/24 |